InvestorsHub Logo
Followers 21
Posts 818
Boards Moderated 0
Alias Born 04/10/2005

Re: 1syndicate post# 1972

Thursday, 12/01/2016 3:57:19 PM

Thursday, December 01, 2016 3:57:19 PM

Post# of 3707
Spana's background is interesting. The two co-founders one of which is Spana own 6.1% which is mostly options ---2010 reverse split reduced co-founders interests because of subsequent capital finanings.

What is Spana's motivation is all this? Sell out? JV so salary of $400,000 continues?

Anyone here talk with Dr. Spana ever?

Carl Spana, Ph.D.

President, Chief Executive Officer and Director

Dr. Spana is a co-founder of Palatin, and has been our Chief Executive Officer and President since June 2000, and from June 1996 through 2000 was our executive vice president and chief technical officer. Previously Dr. Spana was vice president of Paramount Capital Investments, LLC, a biotechnology and biopharmaceutical merchant banking firm, and of The Castle Group Ltd., a medical venture capital firm. From 1991 to 1993, Dr. Spana was a Research Associate at Bristol-Myers Squibb where he was involved in scientific research in the field of immunology.
Dr. Spana received his Ph.D. in molecular biology from The Johns Hopkins University and his B.S. in biochemistry from Rutgers University.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PTN News